- Home
- INBX vs NB Comparison
INBX vs NB Comparison
Compare INBX & NB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBX
- NB
- Stock Information
- Founded
- INBX 2010
- NB 1987
- Country
- INBX United States
- NB United States
- Employees
- INBX N/A
- NB N/A
- Industry
- INBX Biotechnology: Pharmaceutical Preparations
- NB Metal Mining
- Sector
- INBX Health Care
- NB Basic Materials
- Exchange
- INBX Nasdaq
- NB Nasdaq
- Market Cap
- INBX 345.8M
- NB 291.3M
- IPO Year
- INBX 2020
- NB N/A
- Fundamental
- Price
- INBX $25.00
- NB $4.14
- Analyst Decision
- INBX Hold
- NB Strong Buy
- Analyst Count
- INBX 2
- NB 2
- Target Price
- INBX N/A
- NB $4.50
- AVG Volume (30 Days)
- INBX 107.2K
- NB 5.5M
- Earning Date
- INBX 08-13-2025
- NB 09-12-2025
- Dividend Yield
- INBX N/A
- NB N/A
- EPS Growth
- INBX N/A
- NB N/A
- EPS
- INBX N/A
- NB N/A
- Revenue
- INBX $1,400,000.00
- NB N/A
- Revenue This Year
- INBX N/A
- NB N/A
- Revenue Next Year
- INBX N/A
- NB N/A
- P/E Ratio
- INBX N/A
- NB N/A
- Revenue Growth
- INBX N/A
- NB N/A
- 52 Week Low
- INBX $10.81
- NB $1.27
- 52 Week High
- INBX $25.61
- NB $5.09
- Technical
- Relative Strength Index (RSI)
- INBX 65.23
- NB 55.34
- Support Level
- INBX $22.40
- NB $3.50
- Resistance Level
- INBX $24.48
- NB $4.42
- Average True Range (ATR)
- INBX 1.39
- NB 0.57
- MACD
- INBX 0.08
- NB -0.05
- Stochastic Oscillator
- INBX 87.94
- NB 49.47
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About NB NioCorp Developments Ltd.
NioCorp Developments Ltd is engaged in exploration and development of mineral deposits in North America, specifically, the Elk Creek Niobium/Scandium/Titanium property.